Interaction between (-)naloxone and morphine in modifying superoxide generation from human granulocytes

Area of Science:

• Immunology
• Pharmacology
• Cellular Metabolism

Background:

• Superoxide generation by human granulocytes is a key component of the innate immune response.
• Opioid receptors are known to modulate immune cell function, but their precise role in oxidative metabolism is not fully understood.
• Morphine is a potent opioid agonist, while naloxone is an opioid antagonist with stereoisomers that can reveal non-opioid receptor interactions.

Purpose of the Study:

• To investigate the effects of morphine and naloxone stereoisomers on superoxide generation in human granulocytes.
• To determine if opioid receptors mediate the observed effects on oxidative metabolism.
• To explore the potential involvement of non-opioid mechanisms in morphine's interaction with granulocyte function.

Main Methods:

• Human granulocytes were isolated and stimulated with phorbol 12-myristate 13-acetate (PMA).
• Superoxide generation was measured in the presence of varying concentrations of morphine, (-)naloxone, and (+)naloxone, both alone and in combination.
• Statistical analysis was performed to assess the significance of observed effects.

Main Results:

• Neither morphine nor naloxone alone affected basal or PMA-stimulated superoxide generation.
• Combined equimolar concentrations of (-)naloxone and morphine significantly inhibited PMA-stimulated superoxide generation.
• (+)naloxone combined with morphine had no significant effect on superoxide generation, indicating stereospecificity.

Conclusions:

• The stereospecific inhibition of superoxide generation by the (-)naloxone-morphine combination suggests the involvement of opioid receptors.
• The findings indicate that the observed inhibition may result from the unmasking of non-opioid effects of morphine.
• Opioid-mediated control of oxidative metabolism in human granulocytes may involve multiple receptors with opposing actions.